Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yannan, Lian, Yuane, Chen, Xiaoping, Wu, Jiayi, Lai, Jianlin, Qiu, Funan, Zhou, Songqiang, Zhu, Zijing, Tian, Yifeng, Wang, Yaodong, Yang, Yinghong, Yan, Maolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874098/
https://www.ncbi.nlm.nih.gov/pubmed/33585243
http://dx.doi.org/10.3389/fonc.2020.616263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874098/
https://www.ncbi.nlm.nih.gov/pubmed/33585243
http://dx.doi.org/10.3389/fonc.2020.616263

Ejemplares similares